6.10
price up icon0.00%   0.00
after-market Handel nachbörslich: 6.13 0.03 +0.49%
loading

Finanzdaten der Atea Pharmaceuticals Inc-Aktie (AVIR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
20.56%
54.93
45.57 41.34 39.04 39.03
Depreciation and Amortization
0.00%
0.104
0.104 0.104 0.104 0.104
Operating Income/Loss
20.56%
-54.93
-45.57 -41.34 -39.04 -39.03
Income/Loss From Continuing Operations Before Tax
23.37%
-51.63
-41.85 -36.95 -34.07 -33.32
Income Tax Expense/Benefit
3,553%
-6.768
0.196 0.207 0.203 0.225
Income/Loss From Continuing Operations After Tax
6.70%
-44.87
-42.05 -37.16 -34.27 -33.54
Net Income/Loss
6.70%
-44.87
-42.05 -37.16 -34.27 -33.54
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
101.43%
-1.1285
79.05 83.75 85.16 0.0666
Diluted Average Shares
101.43%
-1.1285
79.05 83.75 85.16 0.0666
Basic Earnings Per Share
7.55%
-0.57
-0.53 -0.44 -0.40 -0.40
Diluted Earnings Per Share
7.55%
-0.57
-0.53 -0.44 -0.40 -0.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):